Canada aims for 7-day approval for Phase I trials; rules redefine sponsors.(Canada): An article from: Bioresearch Monitoring Alert

This digital document is an article from Bioresearch Monitoring Alert, published by Washington Information Source on February 1, 2004. The length of the article is 1167 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Canada aims for 7-day approval for Phase I trials; rules redefine sponsors.(Canada)
Author: Tamra Sami
Publication:Bioresearch Monitoring Alert (Newsletter)
Date: February 1, 2004
Publisher: Washington Information Source
Volume: 4 Issue: 2 Page: 1

Distributed by Thomson Gale